ICU Medical, Otsuka team up to boost US IV solutions production
ICU Medical (ICUI) and Otsuka are launching a joint venture focused on boosting IV solutions production and development in North America. Read more here.
BioLife Solutions price target raised to $31 from $28 at TD Cowen
TD Cowen raised the firm’s price target on BioLife Solutions (BLFS) to $31 from $28 and keeps a Buy rating on the shares. The firm said ...
Business Insider20h
BioLife Solutions price target raised to $30 from $28 at Lake Street
Lake Street analyst Thomas Flaten raised the firm’s price target on BioLife Solutions (BLFS) to $30 from $28 and keeps a Buy rating on the shares after the company reported Q3 results ahead of ...
MassDevice1d
Otsuka partners with ICU Medical to enter U.S. IV products market
Baxter recently restarted the highest-throughput IV solutions manufacturing line at the North Cove facility. ICU Medical and ...